The administration of exogenous estradiol activates the phosphoinositide 3-kinase (PI3K)/Akt/endothelial NO synthase (eNOS) pathway, thereby mitigating the severity of AKI through the normalization of NO synthesis [31]. The gene discussed is AKT1; the disease is acute kidney injury.